Lisata Therapeutics Inc. (LSTA) — Cash Flow Reinvestment Rate

Latest as of June 2020: 0.00x

Lisata Therapeutics Inc. (LSTA) has a Cash Flow Reinvestment Rate of 0.00x as of June 2020, reinvesting $12.00K (capex $12.00K ) from operating cash flow of $4.50 Million. See free cash flow generation of Lisata Therapeutics Inc. to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$12.00K
Capex + Investments

Operating Cash Flow

$4.50 Million
USD

Capital Expenditures

$12.00K
USD

Lisata Therapeutics Inc. Cash Flow Reinvestment Rate (1992–2002)

Historical reinvestment intensity for Lisata Therapeutics Inc. across 3 annual periods. For the full cash flow conversion analysis, see LSTA cash flow conversion.

Annual Cash Flow Reinvestment Rate for Lisata Therapeutics Inc. (1992–2002)

Year-by-year capital reinvestment analysis for Lisata Therapeutics Inc.. See LSTA financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2002 0.00x $1.13K $1.01 Million $1.13K ▼ -99.9%
1993 1.06x $500.00K $470.00K $500.00K ▲ +219.1%
1992 0.33x $80.00K $240.00K $80.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow